These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9532649)

  • 1. [Ascolong: a new buccal dosage form of acetylsalicylic acid to be used and antiaggregant].
    Kokurina EV; Suslina ZA; Khromov GL; Davydo AB; Metelitsa VI; Ionova VG; Tanashian MM; Demina EG; Bochkareva EV; Belolipetskaia VG; Deev AD; Kucheriaeva NG; Zidra SI; Gorin NN; Rumiantsev DO
    Ter Arkh; 1998; 70(1):32-7. PubMed ID: 9532649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal low dosage of acetylsalicylic acid (ASA) for the prevention and treatment of ischemic cerebrovascular disease in geriatric patients.
    Ma ZZ; Luo Y; Tang HC; Li CF; Yin ZJ; Li H
    Chin Med J (Engl); 1992 Aug; 105(8):651-6. PubMed ID: 1458968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the pharmacokinetics of acetylsalicylic acid upon transdermal administration].
    Polukhina OS; Basok IuB; Salomatina LA; Sevast'ianov VI
    Eksp Klin Farmakol; 2009; 72(3):29-32. PubMed ID: 19642589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
    Schiff M; Hochberg MC; Oldenhof J; Brune K
    Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transdermic acetylsalicylic acid on hemostasis in healthy volunteers.
    Martínez AB; Funosas E; Maestri L; Lucena PH
    Acta Odontol Latinoam; 2007; 20(1):3-8. PubMed ID: 18046964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.
    Lee PY; Chen WH; Ng W; Cheng X; Kwok JY; Tse HF; Lau CP
    Am J Med; 2005 Jul; 118(7):723-7. PubMed ID: 15989905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
    Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
    Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of acetylsalicylic acid as a platelet antiaggregant].
    de Araújo AR; Sobreira MI; de Melo GO; Mendonca CM; Maranhão EA; Leite MS; Santos FL
    Arq Bras Cardiol; 1992 Aug; 59(2):113-7. PubMed ID: 1341156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked increase of fibrin gel permeability with very low dose ASA treatment.
    Antovic A; Perneby C; Ekman GJ; Wallen HN; Hjemdahl P; Blombäck M; He S
    Thromb Res; 2005; 116(6):509-17. PubMed ID: 16181986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
    Topol EJ; Easton D; Harrington RA; Amarenco P; Califf RM; Graffagnino C; Davis S; Diener HC; Ferguson J; Fitzgerald D; Granett J; Shuaib A; Koudstaal PJ; Theroux P; Van de Werf F; Sigmon K; Pieper K; Vallee M; Willerson JT;
    Circulation; 2003 Jul; 108(4):399-406. PubMed ID: 12874182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
    Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
    J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.